ruboxistaurin has been researched along with pyruvaldehyde in 1 studies
| Studies (ruboxistaurin) | Trials (ruboxistaurin) | Recent Studies (post-2010) (ruboxistaurin) | Studies (pyruvaldehyde) | Trials (pyruvaldehyde) | Recent Studies (post-2010) (pyruvaldehyde) |
|---|---|---|---|---|---|
| 203 | 29 | 56 | 2,458 | 34 | 1,447 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Babcock, SA; Chen, B; Huang, D; Ma, Y; Ren, J; Shen, D; Zhang, C; Zhang, L | 1 |
1 other study(ies) available for ruboxistaurin and pyruvaldehyde
| Article | Year |
|---|---|
Inhibition of protein kinase C βII isoform ameliorates methylglyoxal advanced glycation endproduct-induced cardiomyocyte contractile dysfunction.
Topics: Aconitate Hydratase; Animals; Apoptosis; Blotting, Western; Calcium; Glycation End Products, Advanced; Indoles; Male; Maleimides; Mitochondria; Myocardial Contraction; Myocytes, Cardiac; Oxidative Stress; Protein Kinase C beta; Pyruvaldehyde; Rats; Rats, Sprague-Dawley | 2014 |